Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-23-000380
Filing Date
2023-08-04
Accepted
2023-08-04 10:04:37
Documents
49
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-K sybleu063023form10k.htm   iXBRL 10-K 797873
7 EXHIBIT 10.6 ex10_16.htm EX-10.16 2847
8 EXHIBIT 10.17 ex10_17.htm EX-10.17 2761
9 EXHIBIT 31.1 ex31_1.htm EX-31.1 14990
10 EXHIBIT 31.2 ex31_2.htm EX-31.2 13654
11 EXHIBIT 32.1 ex32_1.htm EX-32.1 2948
12 EXHIBIT 32.2 ex32_2.htm EX-32.2 3480
  Complete submission text file 0001607062-23-000380.txt   2735520

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cik0001818674-20230630.xsd EX-101.SCH 25136
3 XBRL CALCULATION FILE cik0001818674-20230630_cal.xml EX-101.CAL 37116
4 XBRL DEFINITION FILE cik0001818674-20230630_def.xml EX-101.DEF 53284
5 XBRL LABEL FILE cik0001818674-20230630_lab.xml EX-101.LAB 172362
6 XBRL PRESENTATION FILE cik0001818674-20230630_pre.xml EX-101.PRE 139672
43 EXTRACTED XBRL INSTANCE DOCUMENT sybleu063023form10k_htm.xml XML 212765
Mailing Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465
Business Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465 718-795-7790
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 333-248059 | Film No.: 231142498
SIC: 2834 Pharmaceutical Preparations